|Day Low/High||7.02 / 7.07|
|52 Wk Low/High||3.35 / 7.86|
The uptick in the small- and mid-cap space bodes well for future capital appreciation.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Xenoport, Inc.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
The biotechnology company, which makes alcoholism drug Horizant, was acquired by privately held Arbor Pharmaceuticals for $467 million in cash, a price lower than at least one analyst expected.
XenoPort (XNPT) shares are soaring Monday as Arbor Pharmaceuticals agreed to acquire the company in a deal valued at about $467 million.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of XenoPort, Inc.
Monsanto rises and Tribune Publishing sinks on separate merger bids.
XenoPort (XNPT) shares are soaring Monday on the announcement that Arbor Pharmaceuticals will buy the biopharmaceutical company in a deal valued at about$467 million.
Rigrodsky & Long, P.A.
Arbor Pharmaceuticals, LLC (Arbor) and XenoPort, Inc. (XenoPort) (NASDAQ:XNPT) announced today that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.
XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2016.
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 5, 2016 at approximately 4:30 p.
Nearly 7 million Americans suffer from restless legs syndrome (RLS).
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2016 Cowen and Company 36th Annual Health Care Conference.
XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2015.
Insiders at these companies have been scooping up shares of their own stock lately.
XenoPort, Inc. (NASDAQ:XNPT) announced today that it will release its fourth quarter and year-end financial results on February 25, 2016 at approximately 4:30 p.
XenoPort (XNPT) stock is gaining on Friday morning as the company explores the possibility of selling its self.
The most recent short interest data has been released by the NASDAQ for the 11/30/2015 settlement date, which shows a 1,634,591 share increase in total short interest for XenoPort Inc , to 9,959,657, an increase of 19.63% since 11/13/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Trade-Ideas LLC identified XenoPort (XNPT) as a weak on high relative volume candidate
XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2015.
Trade-Ideas LLC identified XenoPort (XNPT) as a "perilous reversal" (up big yesterday but down big today) candidate
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2015 Credit Suisse Healthcare Conference in Phoenix, Arizona.
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2015 at approximately 4:30 p.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.